

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.24278776 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.24278776 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.90625829 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.90625829 |
| 5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.51801145 |
| 6 | aromatic amino acid family catabolic process (GO:0009074) | 6.40303808 |
| 7 | regulation of plasminogen activation (GO:0010755) | 5.87822880 |
| 8 | high-density lipoprotein particle remodeling (GO:0034375) | 5.68226995 |
| 9 | intestinal cholesterol absorption (GO:0030299) | 5.67821899 |
| 10 | indole-containing compound catabolic process (GO:0042436) | 5.65853110 |
| 11 | indolalkylamine catabolic process (GO:0046218) | 5.65853110 |
| 12 | tryptophan catabolic process (GO:0006569) | 5.65853110 |
| 13 | glyoxylate metabolic process (GO:0046487) | 5.60634198 |
| 14 | bile acid biosynthetic process (GO:0006699) | 5.57925236 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.57686434 |
| 16 | kynurenine metabolic process (GO:0070189) | 5.55876615 |
| 17 | negative regulation of fibrinolysis (GO:0051918) | 5.44086835 |
| 18 | regulation of apoptotic cell clearance (GO:2000425) | 5.41923796 |
| 19 | urea metabolic process (GO:0019627) | 5.36302534 |
| 20 | urea cycle (GO:0000050) | 5.36302534 |
| 21 | tryptophan metabolic process (GO:0006568) | 5.34239782 |
| 22 | sulfur amino acid catabolic process (GO:0000098) | 5.25982551 |
| 23 | regulation of fibrinolysis (GO:0051917) | 5.23871377 |
| 24 | cysteine metabolic process (GO:0006534) | 5.22498199 |
| 25 | reverse cholesterol transport (GO:0043691) | 5.12980320 |
| 26 | complement activation, alternative pathway (GO:0006957) | 5.12403351 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.10370042 |
| 28 | protein carboxylation (GO:0018214) | 5.10370042 |
| 29 | regulation of protein activation cascade (GO:2000257) | 5.06515792 |
| 30 | * macromolecular complex remodeling (GO:0034367) | 4.95726277 |
| 31 | * plasma lipoprotein particle remodeling (GO:0034369) | 4.95726277 |
| 32 | * protein-lipid complex remodeling (GO:0034368) | 4.95726277 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 4.95462615 |
| 34 | negative regulation of protein activation cascade (GO:2000258) | 4.94890535 |
| 35 | nitrogen cycle metabolic process (GO:0071941) | 4.92425368 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.92103409 |
| 37 | * regulation of cholesterol esterification (GO:0010872) | 4.81527807 |
| 38 | bile acid metabolic process (GO:0008206) | 4.78431895 |
| 39 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.72879792 |
| 40 | phospholipid efflux (GO:0033700) | 4.71272861 |
| 41 | regulation of complement activation (GO:0030449) | 4.71239209 |
| 42 | homocysteine metabolic process (GO:0050667) | 4.67186287 |
| 43 | amino-acid betaine metabolic process (GO:0006577) | 4.65808892 |
| 44 | aromatic amino acid family metabolic process (GO:0009072) | 4.64048509 |
| 45 | tyrosine metabolic process (GO:0006570) | 4.63210527 |
| 46 | lysine metabolic process (GO:0006553) | 4.56229370 |
| 47 | lysine catabolic process (GO:0006554) | 4.56229370 |
| 48 | alpha-amino acid catabolic process (GO:1901606) | 4.53143682 |
| 49 | acute-phase response (GO:0006953) | 4.52462044 |
| 50 | triglyceride homeostasis (GO:0070328) | 4.50908077 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.50908077 |
| 52 | plasma lipoprotein particle clearance (GO:0034381) | 4.49451474 |
| 53 | negative regulation of sterol transport (GO:0032372) | 4.49059398 |
| 54 | negative regulation of cholesterol transport (GO:0032375) | 4.49059398 |
| 55 | regulation of humoral immune response (GO:0002920) | 4.45154753 |
| 56 | negative regulation of hemostasis (GO:1900047) | 4.43844812 |
| 57 | negative regulation of blood coagulation (GO:0030195) | 4.43844812 |
| 58 | glutamate metabolic process (GO:0006536) | 4.39689468 |
| 59 | epoxygenase P450 pathway (GO:0019373) | 4.37001090 |
| 60 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.32532473 |
| 61 | cellular ketone body metabolic process (GO:0046950) | 4.30855391 |
| 62 | plasma lipoprotein particle assembly (GO:0034377) | 4.30307758 |
| 63 | cholesterol efflux (GO:0033344) | 4.26960438 |
| 64 | * low-density lipoprotein particle remodeling (GO:0034374) | 4.22485965 |
| 65 | positive regulation of hemostasis (GO:1900048) | 4.22481564 |
| 66 | positive regulation of blood coagulation (GO:0030194) | 4.22481564 |
| 67 | proline metabolic process (GO:0006560) | 4.22204982 |
| 68 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.21120974 |
| 69 | cellular amino acid catabolic process (GO:0009063) | 4.20465733 |
| 70 | amine catabolic process (GO:0009310) | 4.09970280 |
| 71 | cellular biogenic amine catabolic process (GO:0042402) | 4.09970280 |
| 72 | regulation of cholesterol biosynthetic process (GO:0045540) | 4.08560697 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.06313655 |
| 74 | negative regulation of coagulation (GO:0050819) | 4.06271397 |
| 75 | coenzyme catabolic process (GO:0009109) | 4.05366136 |
| 76 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.02847644 |
| 77 | indolalkylamine metabolic process (GO:0006586) | 4.02502860 |
| 78 | negative regulation of complement activation (GO:0045916) | 4.02103417 |
| 79 | bile acid and bile salt transport (GO:0015721) | 4.00753879 |
| 80 | glycine metabolic process (GO:0006544) | 3.99766549 |
| 81 | imidazole-containing compound metabolic process (GO:0052803) | 3.99190763 |
| 82 | negative regulation of wound healing (GO:0061045) | 3.93874506 |
| 83 | serine family amino acid metabolic process (GO:0009069) | 3.91561875 |
| 84 | positive regulation of coagulation (GO:0050820) | 3.86468559 |
| 85 | cellular glucuronidation (GO:0052695) | 3.86377240 |
| 86 | fibrinolysis (GO:0042730) | 3.86094690 |
| 87 | arginine metabolic process (GO:0006525) | 3.85830008 |
| 88 | * plasma lipoprotein particle organization (GO:0071827) | 3.85523968 |
| 89 | protein-lipid complex assembly (GO:0065005) | 3.84174202 |
| 90 | benzene-containing compound metabolic process (GO:0042537) | 3.80847497 |
| 91 | cholesterol transport (GO:0030301) | 3.80232284 |
| 92 | sterol transport (GO:0015918) | 3.80232284 |
| 93 | ethanol oxidation (GO:0006069) | 3.78149986 |
| 94 | negative regulation of lipase activity (GO:0060192) | 3.75791627 |
| 95 | positive regulation of lipid catabolic process (GO:0050996) | 3.75424550 |
| 96 | short-chain fatty acid metabolic process (GO:0046459) | 3.75102246 |
| 97 | serine family amino acid biosynthetic process (GO:0009070) | 3.74611790 |
| 98 | phospholipid homeostasis (GO:0055091) | 3.74520612 |
| 99 | ketone body metabolic process (GO:1902224) | 3.72773350 |
| 100 | carboxylic acid catabolic process (GO:0046395) | 3.68396441 |
| 101 | organic acid catabolic process (GO:0016054) | 3.68396441 |
| 102 | drug catabolic process (GO:0042737) | 3.68296449 |
| 103 | blood coagulation, intrinsic pathway (GO:0007597) | 3.67653047 |
| 104 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.66566989 |
| 105 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.66566989 |
| 106 | exogenous drug catabolic process (GO:0042738) | 3.64786343 |
| 107 | cholesterol homeostasis (GO:0042632) | 3.64373069 |
| 108 | * protein-lipid complex subunit organization (GO:0071825) | 3.60829420 |
| 109 | aldehyde catabolic process (GO:0046185) | 3.60419286 |
| 110 | sterol homeostasis (GO:0055092) | 3.58923737 |
| 111 | protein activation cascade (GO:0072376) | 3.58198724 |
| 112 | complement activation (GO:0006956) | 3.56178770 |
| 113 | intestinal absorption (GO:0050892) | 3.56115432 |
| 114 | aspartate family amino acid catabolic process (GO:0009068) | 3.55647180 |
| 115 | carnitine metabolic process (GO:0009437) | 3.55429709 |
| 116 | complement activation, classical pathway (GO:0006958) | 3.55366136 |
| 117 | lipoprotein metabolic process (GO:0042157) | 3.52884603 |
| 118 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.52452489 |
| 119 | regulation of cholesterol homeostasis (GO:2000188) | 3.52264747 |
| 120 | omega-hydroxylase P450 pathway (GO:0097267) | 3.52143265 |
| 121 | cofactor catabolic process (GO:0051187) | 3.50887372 |
| 122 | acetyl-CoA metabolic process (GO:0006084) | 3.47864343 |
| 123 | regulation of bile acid biosynthetic process (GO:0070857) | 3.44883801 |
| 124 | regulation of cholesterol metabolic process (GO:0090181) | 3.40273356 |
| 125 | cytolysis (GO:0019835) | 3.40232568 |
| 126 | acute inflammatory response (GO:0002526) | 3.36424340 |
| 127 | diacylglycerol metabolic process (GO:0046339) | 3.35971835 |
| 128 | glucuronate metabolic process (GO:0019585) | 3.34664940 |
| 129 | uronic acid metabolic process (GO:0006063) | 3.34664940 |
| 130 | lipid homeostasis (GO:0055088) | 3.27587935 |
| 131 | ethanol metabolic process (GO:0006067) | 3.26807720 |
| 132 | response to mercury ion (GO:0046689) | 3.23508533 |
| 133 | negative regulation of lipid transport (GO:0032369) | 3.22634952 |
| 134 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.21034239 |
| 135 | peptidyl-glutamic acid modification (GO:0018200) | 3.18570576 |
| 136 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.11613701 |
| 137 | neutral lipid catabolic process (GO:0046461) | 3.09171566 |
| 138 | acylglycerol catabolic process (GO:0046464) | 3.09171566 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.83641620 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.68021294 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.34828821 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.19838663 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.07837576 |
| 6 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.01355465 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.64408100 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.77082626 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.67305185 |
| 10 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.3925456 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.99225989 |
| 12 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.96542123 |
| 13 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.94865084 |
| 14 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.71537257 |
| 15 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.69512365 |
| 16 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.67020092 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61944887 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47394347 |
| 19 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46775110 |
| 20 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34103905 |
| 21 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.27964627 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.24233712 |
| 23 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18402649 |
| 24 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.17867355 |
| 25 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.08610360 |
| 26 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05695746 |
| 27 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.04641786 |
| 28 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.04538733 |
| 29 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.03825548 |
| 30 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 1.02184347 |
| 31 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.01852989 |
| 32 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98246902 |
| 33 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.97110772 |
| 34 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95469117 |
| 35 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.94578550 |
| 36 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94154826 |
| 37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92773730 |
| 38 | * TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91725008 |
| 39 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.90824294 |
| 40 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.90493417 |
| 41 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.90480404 |
| 42 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.90076463 |
| 43 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.89484682 |
| 44 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86637391 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.86295562 |
| 46 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.86071724 |
| 47 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.85758589 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.85120863 |
| 49 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.84973624 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.84828766 |
| 51 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.84450097 |
| 52 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.84295428 |
| 53 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84283166 |
| 54 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84017516 |
| 55 | * ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83608594 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.83175935 |
| 57 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.83135018 |
| 58 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.77931488 |
| 59 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.77931488 |
| 60 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.77338059 |
| 61 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.76043628 |
| 62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73848772 |
| 63 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.73520279 |
| 64 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.72347297 |
| 65 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.71735939 |
| 66 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71689614 |
| 67 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.71405547 |
| 68 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.70058736 |
| 69 | KDM2B_26808549_Chip-Seq_K562_Human | 0.67647088 |
| 70 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.67527244 |
| 71 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67452153 |
| 72 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.66930105 |
| 73 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.66183574 |
| 74 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.65454015 |
| 75 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.65440396 |
| 76 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.65399678 |
| 77 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.62296855 |
| 78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.62091556 |
| 79 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.61976433 |
| 80 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.61688954 |
| 81 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.61100618 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 0.60724040 |
| 83 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.60624781 |
| 84 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.60602246 |
| 85 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.59882332 |
| 86 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.59707043 |
| 87 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.59707043 |
| 88 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.59420205 |
| 89 | * JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.59210594 |
| 90 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.59000108 |
| 91 | * SOX11_22085726_ChIP-Seq_ESNs_Mouse | 0.58965570 |
| 92 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.58903451 |
| 93 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58162144 |
| 94 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.57962717 |
| 95 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.57888715 |
| 96 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.57268315 |
| 97 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.57118510 |
| 98 | CBP_21632823_ChIP-Seq_H3396_Human | 0.57044902 |
| 99 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.56445021 |
| 100 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.56181003 |
| 101 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.56045596 |
| 102 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.55209238 |
| 103 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54816225 |
| 104 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.53413498 |
| 105 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.53168835 |
| 106 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.52527087 |
| 107 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.52489692 |
| 108 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.52241155 |
| 109 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.51882186 |
| 110 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.51088383 |
| 111 | GATA1_19941826_ChIP-Seq_K562_Human | 0.50748573 |
| 112 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.50086851 |
| 113 | * AR_20517297_ChIP-Seq_VCAP_Human | 0.49678031 |
| 114 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.49434831 |
| 115 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.48883430 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.48698493 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48594827 |
| 118 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48521996 |
| 119 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.48301602 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.46922651 |
| 121 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46281563 |
| 122 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.43913473 |
| 123 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.43847452 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43472309 |
| 125 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.43272129 |
| 126 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.42951495 |
| 127 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.42087333 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42065298 |
| 129 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.41782731 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.41600217 |
| 131 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.41451661 |
| 132 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.41386921 |
| 133 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.40648446 |
| 134 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40600898 |
| 135 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.40579104 |
| 136 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.40436038 |
| 137 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.39662747 |
| 138 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.38880665 |
| 139 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.36898933 |
| 140 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.36809814 |
| 141 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.36801347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.02569137 |
| 2 | MP0005360_urolithiasis | 7.49724263 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.15336075 |
| 4 | MP0005365_abnormal_bile_salt | 5.99695441 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.92024378 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.89625416 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.75965084 |
| 8 | MP0003252_abnormal_bile_duct | 3.65217255 |
| 9 | MP0003122_maternal_imprinting | 3.53783941 |
| 10 | MP0009840_abnormal_foam_cell | 3.52649214 |
| 11 | MP0005083_abnormal_biliary_tract | 2.92753003 |
| 12 | * MP0005332_abnormal_amino_acid | 2.90686206 |
| 13 | MP0003195_calcinosis | 2.84376486 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.51622259 |
| 15 | MP0001666_abnormal_nutrient_absorption | 2.47091143 |
| 16 | MP0000566_synostosis | 2.33747487 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.19844230 |
| 18 | MP0002118_abnormal_lipid_homeostasis | 2.18463746 |
| 19 | MP0000609_abnormal_liver_physiology | 2.11626839 |
| 20 | MP0003123_paternal_imprinting | 1.86505320 |
| 21 | MP0002138_abnormal_hepatobiliary_system | 1.74830719 |
| 22 | MP0003868_abnormal_feces_composition | 1.74664652 |
| 23 | * MP0005319_abnormal_enzyme/_coenzyme | 1.71550531 |
| 24 | MP0003172_abnormal_lysosome_physiology | 1.69826943 |
| 25 | MP0001915_intracranial_hemorrhage | 1.68595765 |
| 26 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.65844538 |
| 27 | MP0001764_abnormal_homeostasis | 1.63135140 |
| 28 | MP0003011_delayed_dark_adaptation | 1.56827921 |
| 29 | MP0009697_abnormal_copulation | 1.52198274 |
| 30 | MP0005670_abnormal_white_adipose | 1.43834033 |
| 31 | MP0003879_abnormal_hair_cell | 1.42555417 |
| 32 | MP0005451_abnormal_body_composition | 1.33630436 |
| 33 | MP0000604_amyloidosis | 1.32721321 |
| 34 | MP0003690_abnormal_glial_cell | 1.31813548 |
| 35 | MP0002254_reproductive_system_inflammat | 1.29490440 |
| 36 | MP0009643_abnormal_urine_homeostasis | 1.29261471 |
| 37 | MP0003186_abnormal_redox_activity | 1.23461348 |
| 38 | MP0000920_abnormal_myelination | 1.20712043 |
| 39 | MP0003656_abnormal_erythrocyte_physiolo | 1.19167643 |
| 40 | MP0002132_abnormal_respiratory_system | 1.16024105 |
| 41 | MP0005647_abnormal_sex_gland | 1.14426178 |
| 42 | MP0003705_abnormal_hypodermis_morpholog | 1.13109292 |
| 43 | MP0009764_decreased_sensitivity_to | 1.08689918 |
| 44 | MP0005409_darkened_coat_color | 1.06305774 |
| 45 | MP0004270_analgesia | 1.04778744 |
| 46 | * MP0000598_abnormal_liver_morphology | 1.03820873 |
| 47 | MP0003329_amyloid_beta_deposits | 1.01611629 |
| 48 | MP0005636_abnormal_mineral_homeostasis | 0.98376060 |
| 49 | MP0009763_increased_sensitivity_to | 0.97955052 |
| 50 | MP0004130_abnormal_muscle_cell | 0.95512714 |
| 51 | MP0003632_abnormal_nervous_system | 0.91982586 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.88317759 |
| 53 | MP0001661_extended_life_span | 0.86742457 |
| 54 | MP0002078_abnormal_glucose_homeostasis | 0.86573175 |
| 55 | MP0003183_abnormal_peptide_metabolism | 0.86542543 |
| 56 | MP0009384_cardiac_valve_regurgitation | 0.86341325 |
| 57 | * MP0009642_abnormal_blood_homeostasis | 0.85524819 |
| 58 | MP0002971_abnormal_brown_adipose | 0.81420333 |
| 59 | MP0008469_abnormal_protein_level | 0.79860895 |
| 60 | MP0005376_homeostasis/metabolism_phenot | 0.79622481 |
| 61 | MP0005535_abnormal_body_temperature | 0.78977175 |
| 62 | MP0002909_abnormal_adrenal_gland | 0.77904718 |
| 63 | * MP0002089_abnormal_postnatal_growth/wei | 0.76224592 |
| 64 | MP0003075_altered_response_to | 0.75970802 |
| 65 | MP0003121_genomic_imprinting | 0.75762466 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.75674076 |
| 67 | MP0006036_abnormal_mitochondrial_physio | 0.75578737 |
| 68 | MP0005334_abnormal_fat_pad | 0.74612609 |
| 69 | MP0000639_abnormal_adrenal_gland | 0.72577528 |
| 70 | MP0005084_abnormal_gallbladder_morpholo | 0.69076856 |
| 71 | MP0009765_abnormal_xenobiotic_induced | 0.69030523 |
| 72 | MP0004272_abnormal_basement_membrane | 0.68628419 |
| 73 | MP0005408_hypopigmentation | 0.67426720 |
| 74 | MP0005666_abnormal_adipose_tissue | 0.65589942 |
| 75 | MP0004043_abnormal_pH_regulation | 0.64610739 |
| 76 | * MP0003631_nervous_system_phenotype | 0.62982402 |
| 77 | MP0005448_abnormal_energy_balance | 0.62171277 |
| 78 | MP0005266_abnormal_metabolism | 0.57281911 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.57277842 |
| 80 | * MP0001756_abnormal_urination | 0.57127195 |
| 81 | MP0002837_dystrophic_cardiac_calcinosis | 0.55261915 |
| 82 | MP0002064_seizures | 0.55174870 |
| 83 | MP0000003_abnormal_adipose_tissue | 0.54910344 |
| 84 | MP0001270_distended_abdomen | 0.52760197 |
| 85 | MP0002249_abnormal_larynx_morphology | 0.51853634 |
| 86 | MP0002822_catalepsy | 0.51840558 |
| 87 | MP0005551_abnormal_eye_electrophysiolog | 0.51776238 |
| 88 | MP0004885_abnormal_endolymph | 0.51602259 |
| 89 | MP0003638_abnormal_response/metabolism_ | 0.51355695 |
| 90 | MP0009053_abnormal_anal_canal | 0.50656146 |
| 91 | MP0003115_abnormal_respiratory_system | 0.50422965 |
| 92 | MP0005395_other_phenotype | 0.50012271 |
| 93 | MP0003953_abnormal_hormone_level | 0.49836814 |
| 94 | MP0003950_abnormal_plasma_membrane | 0.49272579 |
| 95 | MP0005257_abnormal_intraocular_pressure | 0.49167677 |
| 96 | MP0003878_abnormal_ear_physiology | 0.49116969 |
| 97 | MP0005377_hearing/vestibular/ear_phenot | 0.49116969 |
| 98 | MP0008874_decreased_physiological_sensi | 0.48815915 |
| 99 | MP0002282_abnormal_trachea_morphology | 0.46993698 |
| 100 | MP0008872_abnormal_physiological_respon | 0.46948791 |
| 101 | MP0005166_decreased_susceptibility_to | 0.46939057 |
| 102 | MP0008569_lethality_at_weaning | 0.46795550 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.46677627 |
| 104 | MP0002933_joint_inflammation | 0.45805985 |
| 105 | MP0000230_abnormal_systemic_arterial | 0.44676012 |
| 106 | MP0003634_abnormal_glial_cell | 0.44049853 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.43269274 |
| 108 | MP0006054_spinal_hemorrhage | 0.41196054 |
| 109 | MP0004883_abnormal_blood_vessel | 0.40960854 |
| 110 | MP0002168_other_aberrant_phenotype | 0.40819932 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.40460556 |
| 112 | MP0001853_heart_inflammation | 0.39664357 |
| 113 | MP0005464_abnormal_platelet_physiology | 0.39438291 |
| 114 | MP0000579_abnormal_nail_morphology | 0.37877088 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.37009416 |
| 116 | MP0003724_increased_susceptibility_to | 0.36901358 |
| 117 | MP0001881_abnormal_mammary_gland | 0.36564124 |
| 118 | MP0001984_abnormal_olfaction | 0.36295139 |
| 119 | MP0005164_abnormal_response_to | 0.36252824 |
| 120 | MP0001486_abnormal_startle_reflex | 0.36094296 |
| 121 | MP0005410_abnormal_fertilization | 0.35950740 |
| 122 | MP0005023_abnormal_wound_healing | 0.35614868 |
| 123 | MP0005595_abnormal_vascular_smooth | 0.35493075 |
| 124 | * MP0003633_abnormal_nervous_system | 0.35006658 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.34920891 |
| 126 | MP0001324_abnormal_eye_pigmentation | 0.34735673 |
| 127 | MP0002090_abnormal_vision | 0.33918312 |
| 128 | * MP0009115_abnormal_fat_cell | 0.33660280 |
| 129 | MP0002557_abnormal_social/conspecific_i | 0.33529544 |
| 130 | MP0009672_abnormal_birth_weight | 0.33436922 |
| 131 | MP0003718_maternal_effect | 0.33170795 |
| 132 | MP0002796_impaired_skin_barrier | 0.33163991 |
| 133 | MP0008873_increased_physiological_sensi | 0.33056090 |
| 134 | MP0005248_abnormal_Harderian_gland | 0.32835481 |
| 135 | * MP0000249_abnormal_blood_vessel | 0.32240524 |
| 136 | MP0005646_abnormal_pituitary_gland | 0.32199191 |
| 137 | MP0002970_abnormal_white_adipose | 0.31293424 |
| 138 | MP0009780_abnormal_chondrocyte_physiolo | 0.29848630 |
| 139 | MP0002928_abnormal_bile_duct | 0.26622690 |
| 140 | MP0004782_abnormal_surfactant_physiolog | 0.26590818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.16470541 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.10357694 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 6.89702632 |
| 4 | Xanthomatosis (HP:0000991) | 6.37030193 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 6.36075893 |
| 6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.23350697 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.01838180 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.80771827 |
| 9 | Complement deficiency (HP:0004431) | 5.22822567 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.93010050 |
| 11 | Joint hemorrhage (HP:0005261) | 4.78648151 |
| 12 | Hypoalphalipoproteinemia (HP:0003233) | 4.68105796 |
| 13 | Hyperammonemia (HP:0001987) | 4.63381577 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.48312091 |
| 15 | Hyperglycinemia (HP:0002154) | 4.38856336 |
| 16 | Ketosis (HP:0001946) | 4.38478074 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.35336702 |
| 18 | Epidermoid cyst (HP:0200040) | 4.34033447 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.30804834 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.26674988 |
| 21 | Hyperglycinuria (HP:0003108) | 4.20183539 |
| 22 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.14546227 |
| 23 | Abnormality of glycine metabolism (HP:0010895) | 4.09747224 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.09747224 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08672912 |
| 26 | Hypoglycemic coma (HP:0001325) | 4.00004833 |
| 27 | Fat malabsorption (HP:0002630) | 3.81231570 |
| 28 | Abnormality of complement system (HP:0005339) | 3.75977386 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.62071881 |
| 30 | Abnormality of the intrinsic pathway (HP:0010989) | 3.58408124 |
| 31 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.43740536 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.41041835 |
| 33 | Ketoacidosis (HP:0001993) | 3.36275152 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.30365058 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.22314535 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.20836581 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.13178392 |
| 38 | Purpura (HP:0000979) | 3.12462077 |
| 39 | Nephritis (HP:0000123) | 3.02331721 |
| 40 | Spontaneous abortion (HP:0005268) | 2.96641082 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.93698599 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 2.86744700 |
| 43 | Myocardial infarction (HP:0001658) | 2.85418262 |
| 44 | Steatorrhea (HP:0002570) | 2.82524463 |
| 45 | Hepatocellular carcinoma (HP:0001402) | 2.80615680 |
| 46 | Vascular calcification (HP:0004934) | 2.79941496 |
| 47 | Skin nodule (HP:0200036) | 2.76749104 |
| 48 | Amyloidosis (HP:0011034) | 2.73053438 |
| 49 | Metabolic acidosis (HP:0001942) | 2.72398161 |
| 50 | Abnormality of carpal bone ossification (HP:0006257) | 2.71567760 |
| 51 | Hypoglycemic seizures (HP:0002173) | 2.69492543 |
| 52 | Abnormality of purine metabolism (HP:0004352) | 2.68677630 |
| 53 | Lethargy (HP:0001254) | 2.62909681 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.60033904 |
| 55 | Gout (HP:0001997) | 2.58925935 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.58767436 |
| 57 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.53899436 |
| 58 | Dicarboxylic aciduria (HP:0003215) | 2.53899436 |
| 59 | Cardiovascular calcification (HP:0011915) | 2.48437428 |
| 60 | Abnormal tarsal ossification (HP:0008369) | 2.47085792 |
| 61 | Glomerulonephritis (HP:0000099) | 2.45528563 |
| 62 | Mitral stenosis (HP:0001718) | 2.40515571 |
| 63 | Small epiphyses (HP:0010585) | 2.38944855 |
| 64 | Acanthocytosis (HP:0001927) | 2.38723959 |
| 65 | Irritability (HP:0000737) | 2.35749762 |
| 66 | Arthropathy (HP:0003040) | 2.31686551 |
| 67 | Cerebral edema (HP:0002181) | 2.31683074 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.31499298 |
| 69 | Confusion (HP:0001289) | 2.31144297 |
| 70 | Neonatal onset (HP:0003623) | 2.29420097 |
| 71 | Spastic diplegia (HP:0001264) | 2.27112615 |
| 72 | Osteomalacia (HP:0002749) | 2.25597009 |
| 73 | Gingival bleeding (HP:0000225) | 2.25202971 |
| 74 | Cholelithiasis (HP:0001081) | 2.24895220 |
| 75 | Broad alveolar ridges (HP:0000187) | 2.23561497 |
| 76 | Sensorimotor neuropathy (HP:0007141) | 2.21486580 |
| 77 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.20664338 |
| 78 | Increased serum pyruvate (HP:0003542) | 2.19483853 |
| 79 | Late onset (HP:0003584) | 2.19231045 |
| 80 | Cholecystitis (HP:0001082) | 2.18969607 |
| 81 | Abnormal gallbladder physiology (HP:0012438) | 2.18969607 |
| 82 | Enlarged kidneys (HP:0000105) | 2.18481045 |
| 83 | Pulmonary embolism (HP:0002204) | 2.13007841 |
| 84 | Pancreatitis (HP:0001733) | 2.10699433 |
| 85 | Vomiting (HP:0002013) | 2.06670320 |
| 86 | Esophageal varix (HP:0002040) | 2.06609248 |
| 87 | Alacrima (HP:0000522) | 2.06136958 |
| 88 | Brushfield spots (HP:0001088) | 2.05692136 |
| 89 | Abnormality of glycolysis (HP:0004366) | 2.05636293 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.04988503 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 2.04619127 |
| 92 | Flat acetabular roof (HP:0003180) | 2.04446202 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04279526 |
| 94 | Generalized aminoaciduria (HP:0002909) | 2.04014963 |
| 95 | Malnutrition (HP:0004395) | 2.02292861 |
| 96 | Alkalosis (HP:0001948) | 2.00228751 |
| 97 | Menorrhagia (HP:0000132) | 1.99918316 |
| 98 | Abnormal hand bone ossification (HP:0010660) | 1.99555659 |
| 99 | Status epilepticus (HP:0002133) | 1.99288176 |
| 100 | Abnormal ossification of hand bones (HP:0005921) | 1.99072519 |
| 101 | Thrombophlebitis (HP:0004418) | 1.98979888 |
| 102 | Vaginal fistula (HP:0004320) | 1.95734422 |
| 103 | Asymmetry of the thorax (HP:0001555) | 1.94558695 |
| 104 | Hemorrhage of the eye (HP:0011885) | 1.93159594 |
| 105 | Abnormality of the lumbar spine (HP:0100712) | 1.91341686 |
| 106 | Opisthotonus (HP:0002179) | 1.91032310 |
| 107 | Abnormality of the gallbladder (HP:0005264) | 1.90585042 |
| 108 | Abnormality of proline metabolism (HP:0010907) | 1.90341491 |
| 109 | Hydroxyprolinuria (HP:0003080) | 1.90341491 |
| 110 | Rickets (HP:0002748) | 1.89377559 |
| 111 | Tetraplegia (HP:0002445) | 1.89234875 |
| 112 | Hypertriglyceridemia (HP:0002155) | 1.87352010 |
| 113 | Hypophosphatemic rickets (HP:0004912) | 1.86084405 |
| 114 | Bifid scrotum (HP:0000048) | 1.86037397 |
| 115 | Poikilocytosis (HP:0004447) | 1.85100781 |
| 116 | Hepatoblastoma (HP:0002884) | 1.84911248 |
| 117 | Back pain (HP:0003418) | 1.80838771 |
| 118 | Hyperglycemia (HP:0003074) | 1.79365765 |
| 119 | Hyperuricemia (HP:0002149) | 1.78640550 |
| 120 | Increased purine levels (HP:0004368) | 1.78640550 |
| 121 | Broad palm (HP:0001169) | 1.77405076 |
| 122 | Impaired pain sensation (HP:0007328) | 1.76498912 |
| 123 | Abnormality of pain sensation (HP:0010832) | 1.76498912 |
| 124 | Epiphyseal dysplasia (HP:0002656) | 1.75981968 |
| 125 | Symptomatic seizures (HP:0011145) | 1.75834535 |
| 126 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.75558318 |
| 127 | Scanning speech (HP:0002168) | 1.69616110 |
| 128 | Retinal atrophy (HP:0001105) | 1.69483891 |
| 129 | Abnormality of the nasal septum (HP:0000419) | 1.69430370 |
| 130 | Neurofibrillary tangles (HP:0002185) | 1.61177989 |
| 131 | Abnormal delivery (HP:0001787) | 1.60291884 |
| 132 | Neonatal death (HP:0003811) | 1.59217680 |
| 133 | Pigmentary retinal degeneration (HP:0001146) | 1.58701103 |
| 134 | Bronchomalacia (HP:0002780) | 1.58316062 |
| 135 | Epistaxis (HP:0000421) | 1.56874215 |
| 136 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.56503586 |
| 137 | Prenatal maternal abnormality (HP:0002686) | 1.49978976 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.49625384 |
| 139 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.49625384 |
| 140 | Flared iliac wings (HP:0002869) | 1.49152350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.69982786 |
| 2 | SIK1 | 4.74815025 |
| 3 | FGFR4 | 4.16893770 |
| 4 | ERN1 | 4.12109266 |
| 5 | INSRR | 3.17056808 |
| 6 | TYRO3 | 2.88717548 |
| 7 | NTRK3 | 2.75628807 |
| 8 | WNK4 | 2.56192032 |
| 9 | ERBB4 | 2.55837909 |
| 10 | TAOK3 | 2.46230290 |
| 11 | MAP2K4 | 2.27125647 |
| 12 | MST1R | 1.97550214 |
| 13 | CDK12 | 1.96502248 |
| 14 | TRIB3 | 1.95402913 |
| 15 | MAPK11 | 1.91246984 |
| 16 | PKN2 | 1.84512212 |
| 17 | FGFR1 | 1.78260073 |
| 18 | FLT3 | 1.66626376 |
| 19 | PIK3CG | 1.62586569 |
| 20 | CAMK1D | 1.53819578 |
| 21 | DAPK2 | 1.45199578 |
| 22 | LATS1 | 1.41150115 |
| 23 | PINK1 | 1.41115972 |
| 24 | WNK1 | 1.40421757 |
| 25 | PTK6 | 1.39802959 |
| 26 | SIK2 | 1.39764398 |
| 27 | MAPK12 | 1.38882898 |
| 28 | FGFR2 | 1.31771151 |
| 29 | PRKAA2 | 1.27866090 |
| 30 | MAP3K2 | 1.25484601 |
| 31 | TYK2 | 1.19348992 |
| 32 | JAK2 | 1.19108710 |
| 33 | AKT3 | 1.18886738 |
| 34 | ABL2 | 1.18292527 |
| 35 | FRK | 1.07988353 |
| 36 | DDR2 | 1.06097930 |
| 37 | KSR2 | 1.04046918 |
| 38 | SGK1 | 1.03222988 |
| 39 | MAPK4 | 1.01982333 |
| 40 | MAP3K7 | 1.01928466 |
| 41 | SGK3 | 1.00970503 |
| 42 | EEF2K | 1.00566586 |
| 43 | SGK2 | 0.97666222 |
| 44 | CAMK1G | 0.96947488 |
| 45 | NEK9 | 0.96257546 |
| 46 | STK38L | 0.96064519 |
| 47 | CAMK2G | 0.95488282 |
| 48 | PRKCZ | 0.92604919 |
| 49 | PRKACG | 0.91744580 |
| 50 | JAK1 | 0.91411784 |
| 51 | MAPK15 | 0.91026125 |
| 52 | MET | 0.90625760 |
| 53 | KDR | 0.86057897 |
| 54 | GRK6 | 0.85629839 |
| 55 | PRKAA1 | 0.84676525 |
| 56 | SGK223 | 0.83826516 |
| 57 | SGK494 | 0.83826516 |
| 58 | RIPK1 | 0.83067723 |
| 59 | ERBB2 | 0.82110947 |
| 60 | MARK1 | 0.80974110 |
| 61 | MAPK7 | 0.78808493 |
| 62 | PRKCG | 0.77365676 |
| 63 | UHMK1 | 0.73331234 |
| 64 | FGR | 0.72782389 |
| 65 | RPS6KB1 | 0.72608011 |
| 66 | IRAK3 | 0.72400516 |
| 67 | EPHB1 | 0.70139813 |
| 68 | FGFR3 | 0.69110328 |
| 69 | BRSK1 | 0.68971374 |
| 70 | EPHA4 | 0.68317979 |
| 71 | EPHA3 | 0.67565054 |
| 72 | CSNK1E | 0.66511070 |
| 73 | LMTK2 | 0.64139255 |
| 74 | TIE1 | 0.63837965 |
| 75 | GSK3A | 0.63795839 |
| 76 | PDPK1 | 0.63274988 |
| 77 | IGF1R | 0.63222603 |
| 78 | TBK1 | 0.61675476 |
| 79 | DYRK1B | 0.61485563 |
| 80 | MARK2 | 0.59278148 |
| 81 | PHKG1 | 0.58817774 |
| 82 | PHKG2 | 0.58817774 |
| 83 | EIF2AK1 | 0.58360998 |
| 84 | PDK4 | 0.57821626 |
| 85 | PDK3 | 0.57821626 |
| 86 | MAPKAPK3 | 0.57709775 |
| 87 | MAP2K3 | 0.57561261 |
| 88 | CDK6 | 0.57040027 |
| 89 | MAP3K3 | 0.56449430 |
| 90 | LATS2 | 0.55990130 |
| 91 | PTK2 | 0.53783245 |
| 92 | RPS6KA3 | 0.53327299 |
| 93 | CDC42BPA | 0.52469434 |
| 94 | CSK | 0.52076021 |
| 95 | TNK2 | 0.52057912 |
| 96 | MAPK10 | 0.50968849 |
| 97 | CSNK1D | 0.50252951 |
| 98 | PRKCQ | 0.49781143 |
| 99 | PDGFRA | 0.49360949 |
| 100 | SRC | 0.49231352 |
| 101 | EPHA2 | 0.48882619 |
| 102 | PRKG1 | 0.48800082 |
| 103 | RET | 0.48453656 |
| 104 | MTOR | 0.47970012 |
| 105 | MAP2K1 | 0.47687168 |
| 106 | STK38 | 0.46855986 |
| 107 | PRKD3 | 0.45754302 |
| 108 | MAP2K6 | 0.45532832 |
| 109 | NTRK2 | 0.44808887 |
| 110 | PKN1 | 0.44794643 |
| 111 | NEK6 | 0.44198266 |
| 112 | PIK3CA | 0.44186504 |
| 113 | PRKCA | 0.43441269 |
| 114 | BMX | 0.43200693 |
| 115 | NTRK1 | 0.43132133 |
| 116 | MAP3K13 | 0.42465436 |
| 117 | CDK5 | 0.42226933 |
| 118 | MINK1 | 0.42128346 |
| 119 | MAP3K9 | 0.40479409 |
| 120 | PAK3 | 0.39851650 |
| 121 | PDK1 | 0.39770304 |
| 122 | WNK3 | 0.38781987 |
| 123 | SMG1 | 0.37619192 |
| 124 | TGFBR2 | 0.34437941 |
| 125 | MAP3K14 | 0.34157694 |
| 126 | PDGFRB | 0.34156788 |
| 127 | CSNK1G1 | 0.33807479 |
| 128 | MAP3K1 | 0.33788342 |
| 129 | CAMK4 | 0.33718963 |
| 130 | CSF1R | 0.33450135 |
| 131 | MAP3K11 | 0.33294434 |
| 132 | IRAK2 | 0.32669079 |
| 133 | ALK | 0.32200792 |
| 134 | CAMK2D | 0.32057131 |
| 135 | CAMK2B | 0.31430531 |
| 136 | STK39 | 0.31347404 |
| 137 | PRKCH | 0.31296629 |
| 138 | CDK15 | 0.30716797 |
| 139 | CAMKK1 | 0.30290936 |
| 140 | EGFR | 0.30110904 |
| 141 | PRKACA | 0.30063944 |
| 142 | ICK | 0.30031000 |
| 143 | CDK7 | 0.29905728 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.30687337 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.24343687 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17530306 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.10322095 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07642470 |
| 6 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.68786273 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.65195392 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.61108146 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.60414457 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.56379714 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49135201 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.43915767 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.17240662 |
| 14 | Peroxisome_Homo sapiens_hsa04146 | 2.07634280 |
| 15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.05363926 |
| 16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.05217139 |
| 17 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.03073137 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00317174 |
| 19 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.00250685 |
| 20 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.81930144 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.81584459 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78243155 |
| 23 | Histidine metabolism_Homo sapiens_hsa00340 | 1.78222706 |
| 24 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74706624 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72220922 |
| 26 | Bile secretion_Homo sapiens_hsa04976 | 1.70260855 |
| 27 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.67858554 |
| 28 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58484437 |
| 29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.57856212 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.56010799 |
| 31 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.54506318 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.53911933 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52027547 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51455125 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48697668 |
| 36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.41422423 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.38809248 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38367793 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.35785940 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35728659 |
| 41 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.30949432 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.28507762 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27034229 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.21995562 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19597259 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.19441819 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.15236402 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.12959770 |
| 49 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06692192 |
| 50 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04120083 |
| 51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.02314655 |
| 52 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00357034 |
| 53 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00052715 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96574480 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96509828 |
| 56 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.92999179 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85850895 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.85667358 |
| 59 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84237959 |
| 60 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.83223100 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.81683056 |
| 62 | Lysine degradation_Homo sapiens_hsa00310 | 0.78693888 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71213646 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.58876857 |
| 65 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57227678 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55827981 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.50305399 |
| 68 | Pertussis_Homo sapiens_hsa05133 | 0.46658573 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45738979 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.37790064 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.34409321 |
| 72 | Prion diseases_Homo sapiens_hsa05020 | 0.33877640 |
| 73 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.30940063 |
| 74 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.30776104 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.30237140 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.29294166 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.26866216 |
| 78 | Insulin resistance_Homo sapiens_hsa04931 | 0.25612670 |
| 79 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25530605 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.20996733 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.15520010 |
| 82 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14076305 |
| 83 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.11354392 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.06800783 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.03428812 |
| 86 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2105014 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.2015533 |
| 88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1991406 |
| 89 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1903689 |
| 90 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1810045 |
| 91 | Lysosome_Homo sapiens_hsa04142 | -0.1787436 |
| 92 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1667142 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1521086 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1398221 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | -0.1282056 |
| 96 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1252249 |
| 97 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1087504 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1032657 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.0981264 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0949042 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0700826 |
| 102 | Amoebiasis_Homo sapiens_hsa05146 | -0.0673326 |
| 103 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0658167 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0391347 |
| 105 | Insulin secretion_Homo sapiens_hsa04911 | -0.0317071 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0295245 |
| 107 | Glutamatergic synapse_Homo sapiens_hsa04724 | -0.0289203 |
| 108 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0285658 |
| 109 | Long-term potentiation_Homo sapiens_hsa04720 | -0.0270276 |
| 110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | -0.0250470 |
| 111 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0145673 |
| 112 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0075070 |

